ATE132039T1 - Verwendung von steroidderivaten zur behandlung der endometriose - Google Patents

Verwendung von steroidderivaten zur behandlung der endometriose

Info

Publication number
ATE132039T1
ATE132039T1 AT91105883T AT91105883T ATE132039T1 AT E132039 T1 ATE132039 T1 AT E132039T1 AT 91105883 T AT91105883 T AT 91105883T AT 91105883 T AT91105883 T AT 91105883T AT E132039 T1 ATE132039 T1 AT E132039T1
Authority
AT
Austria
Prior art keywords
treat endometriosis
steroid derivatives
endometriosis
treat
androstene
Prior art date
Application number
AT91105883T
Other languages
English (en)
Inventor
Nobuaki Fujise
Yasushi Yamashita
Hiroaki Takaoka
Nobuyoshi Honda
Makoto Yoshihama
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of ATE132039T1 publication Critical patent/ATE132039T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT91105883T 1990-04-12 1991-04-12 Verwendung von steroidderivaten zur behandlung der endometriose ATE132039T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2097379A JP2602456B2 (ja) 1990-04-12 1990-04-12 子宮内膜症治療剤

Publications (1)

Publication Number Publication Date
ATE132039T1 true ATE132039T1 (de) 1996-01-15

Family

ID=14190880

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105883T ATE132039T1 (de) 1990-04-12 1991-04-12 Verwendung von steroidderivaten zur behandlung der endometriose

Country Status (5)

Country Link
US (1) US5166200A (de)
EP (1) EP0451869B1 (de)
JP (1) JP2602456B2 (de)
AT (1) ATE132039T1 (de)
DE (1) DE69115745T2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567828A (en) * 1995-06-07 1996-10-22 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
UA74168C2 (uk) * 1999-10-05 2005-11-15 Коламбіа Леборетеріс (Бермуда) Лімітед Лікування ендометріозу або безпліддя, або покращення плідності та застосування бета-адренергічного агоніста для виробництва лікарського засобу
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
EP1450849A4 (de) * 2001-11-06 2005-06-29 Applied Research Systems Verfahren zur behandlung von endometreose
GB0302572D0 (en) 2003-02-05 2003-03-12 Astrazeneca Ab Method of treatment
US20050101579A1 (en) * 2003-11-06 2005-05-12 Shippen Eugene R. Endometriosis treatment protocol
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8605405D0 (en) * 1986-03-05 1986-04-09 Erba Farmitalia 3-deoxo-10beta-alkynyl steroids
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
GB8617107D0 (en) * 1986-07-14 1986-08-20 Erba Farmitalia 6-/7-methylenandrosta-1 4-diene-3 17-dione derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
ATE78825T1 (de) * 1987-02-06 1992-08-15 Snow Brand Milk Products Co Ltd Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung.
JPS63192794A (ja) * 1987-02-06 1988-08-10 Snow Brand Milk Prod Co Ltd 14α−ヒドロキシ−4−アンドロステン−3,6,17−トリオン
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
JPH01131193A (ja) * 1987-08-07 1989-05-24 Snow Brand Milk Prod Co Ltd 14α−ヒドロキシ−アンドロスト−4−エン−3,6,17−トリオンのエステル誘導体

Also Published As

Publication number Publication date
US5166200A (en) 1992-11-24
DE69115745T2 (de) 1996-05-15
DE69115745D1 (de) 1996-02-08
JP2602456B2 (ja) 1997-04-23
EP0451869A2 (de) 1991-10-16
EP0451869B1 (de) 1995-12-27
EP0451869A3 (en) 1992-07-08
JPH03294230A (ja) 1991-12-25

Similar Documents

Publication Publication Date Title
SE7903186L (sv) Cerebralverksamt medel
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO912630D0 (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler.
NO147987C (no) 1,2,3-thiadiazol-5-carboxylsyrederivater med herbicid vekstregulerende virkning
ATE121295T1 (de) Augentropfenarzneimittel.
TW248519B (de)
ATE132039T1 (de) Verwendung von steroidderivaten zur behandlung der endometriose
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
DE3853804D1 (de) Zearalanol-Derivate mit anabolytischer Wirkung.
ATE122681T1 (de) 19-substituierte progesterone als 19-hydroxylase- inhibitoren.
HU910694D0 (en) Process for stabilizing 3-isothiazoles by means of hexamethylenetetramine
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
MD1762B2 (ro) Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile
TW366259B (en) N-arylthiohydrazone derivatives as insecticidal and acaricidal agents
ZA91762B (en) Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
IT1162680B (it) N-(1-metil 2-pirrolidinilmetil) 2,3 dimetossi-5-metilsolfamoil benzammi de e suoi derivati utili per il trattamento dei disturbi dell'apparato urinario e procedimento di preparazione
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
MY109202A (en) Isothiazole derivatives and processes for preparing the same as well as termite controlling agents comprising the same as active ingredient
MY131655A (en) Amide derivatives,their production processes and their compositions for the control of insect pests

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee